M
Description
Biopharmaceutical company founded in 2012 in Ann Arbor, Michigan (spun out from University of Michigan), specialized in treatments for rare endocrine diseases including Prader-Willi syndrome, congenital adrenal hyperplasia and Cushing's syndrome. Listed on NASDAQ as MLND.